FIELD: chemistry.
SUBSTANCE: invention relates to a method for producing a compound represented by the chemical formula 1, which exhibits an inhibitory effect on ITK (interleukin-2 tyrosine kinase) and BTK (Bruton's tyrosine kinase). The proposed method includes stages 1)–3). In step 1), a compound represented by the chemical formula 1-3 is obtained by reaction of the compound represented by the chemical formula 1-1 with a compound represented by the chemical formula 1-2 in the presence of a palladium catalyst and a base. In step 2), a compound represented by the chemical formula 1-4 is obtained by reaction of the compound represented by the chemical formula 1-3 in the presence of an acid. In step 3), a compound represented by the chemical formula 1 is obtained by reaction of the compound represented by the chemical formula 1-4 with the compound represented by the chemical formula 1-5 in the presence of a base.
EFFECT: proposed method allows to obtain a compound represented by the chemical formula 1, with a high yield and a reduced content of impurities.
16 cl, 3 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
NEW HETEROCYCLIC AMINE DERIVATIVE AND A PHARMACEUTICAL COMPOSITION CONTAINING IT | 2019 |
|
RU2760184C1 |
NEW PHENYLPYRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE | 2018 |
|
RU2748945C1 |
CRYSTAL OF PYRROLOPYRIMIDINE FOR OBTAINING JAK INHIBITOR | 2017 |
|
RU2746045C2 |
DERIVATIVES OF (AZETHIDINE-1-YLALKYL)-LACTAMES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT OF HUMANS WHEN PATIENTS ARE TREATED BY PRODUCING ANTAGONISTIC EFFECT ON TACHYKININ ACTING IN HUMAN NK-, NK- AND NK-RECEPTORS OR IN THEIR COMBINATION | 1995 |
|
RU2150468C1 |
NITROGEN-CONTAINING SPIROCYCLIC COMPOUND AND ITS APPLICATION IN MEDICINE | 2010 |
|
RU2630694C2 |
USE OF MONOCYCLIC β-LACTAM COMPOUND IN PHARMACY | 2019 |
|
RU2785715C1 |
NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2021 |
|
RU2814288C1 |
NOVEL FUSED PYRIMIDINE COMPOUND OR SALT THEREOF | 2014 |
|
RU2666349C2 |
CASPASE INHIBITORS | 1999 |
|
RU2274642C2 |
THIENODIAZEPINE DERIVATIVES AND THEIR USE | 2018 |
|
RU2795005C2 |
Authors
Dates
2023-05-16—Published
2021-02-26—Filed